Search Count: 4
 |
Egfr Kinase Domain In Complex With 2-(6,7-Dihydro-5H-Pyrrolo[1,2-C]Imidazol-1-Yl)-2-[6-[2-[4-[[4-(Hydroxymethyl)-1-Piperidyl]Methyl]Phenyl]Ethynyl]-1-Oxo-4-(Trifluoromethyl)Isoindolin-2-Yl]-N-Thiazol-2-Yl-Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.07 Å Release Date: 2022-10-19 Classification: TRANSFERASE Ligands: EDO, KY9, NO3 |
 |
Egfr Kinase Domain In Complex With 2-(6,7-Dihydro-5H-Pyrrolo[1,2-C]Imidazol-1-Yl)-2-[6-[2-[4-[[4-(Hydroxymethyl)-1-Piperidyl]Methyl]Phenyl]Ethynyl]-1-Oxo-4-(Trifluoromethyl)Isoindolin-2-Yl]-N-Thiazol-2-Yl-Acetamide (Form 2)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.43 Å Release Date: 2022-10-19 Classification: TRANSFERASE Ligands: KY9, SO4 |
 |
Egfr Kinase Domain (L858R/V948R) In Complex With 2-(6,7-Dihydro-5H-Pyrrolo[1,2-C]Imidazol-1-Yl)-2-[6-[2-[4-[[4-(Hydroxymethyl)-1-Piperidyl]Methyl]Phenyl]Ethynyl]-1-Oxo-4-(Trifluoromethyl)Isoindolin-2-Yl]-N-Thiazol-2-Yl-Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2022-10-19 Classification: TRANSFERASE Ligands: KY9 |
 |
Egfr Kinase Domain (L858R/V948R) In Complex With 2-[4-(Difluoromethyl)-6-[2-[4-[[4-(Hydroxymethyl)-1-Piperidyl]Methyl]Phenyl]Ethynyl]-7-Methyl-Indazol-2-Yl]-2-Spiro[6,7-Dihydropyrrolo[1,2-C]Imidazole-5,1'-Cyclopropane]-1-Yl-N-Thiazol-2-Yl-Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.11 Å Release Date: 2022-10-19 Classification: TRANSFERASE Ligands: EDO, MES, KXY |